ROIV ROIVANT SCIENCES LTD Investor Conferences 8-K Filing 2025 - Program Update On March 19, 2025, Roivant Sciences Ltd. announced an update on its myasthenia gravis and chronic inflammatory demyelinating polyneuropathy programs at Immunovant and scheduled a conference call to discuss trial results.Get access to all SEC 8-K filings of the ROIVANT SCIENCES LTD